从临床的角度回顾呼吸道传染病对COPD病人影响的研究进展与思考
The Research Progress and Consideration on the Influence of Respiratory Infectious Dis-eases on COPD Patients Were Reviewed from the Clinical Perspective
DOI: 10.12677/ACM.2023.13112425, PDF,   
作者: 程晓雨：青海大学研究生院，青海 西宁；冯恩志*：中国人民解放军联勤保障部队第941医院呼吸内科，青海 西宁
关键词: 慢性阻塞性肺疾病；新型冠状病毒肺炎；Chronic Obstructive Pulmonary Disease； COVID-19
摘要: 慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)是一种常见的以持续气流受限为特征的可以预防和治疗的疾病，据估计，70%~80%的COPD急性加重是由病毒或细菌性呼吸道感染所引发。新型冠状病毒肺炎(新冠肺炎，COVID-19)是一种急性感染性肺炎，其病原体是一种先前未在人类中发现的新型冠状病毒。该综述系统总结了COVID-19大流行期间COPD病人的相关危险性，并对感染了COVID-19的COPD患者特点、未感染或感染COVID-19的COPD病人的治疗等方面的研究进展进行系统阐述，为呼吸道传染病流行期间保护COPD人群提供一条思路。
Abstract: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by persistent airflow limitation. It has been estimated that between 70% and 80% of acute exacerbations of COPD are triggered by viral or bacterial respiratory infections. Coronavirus disease 2019 (COVID-19) is an acute infectious pneumonia caused by a novel coronavirus that has not been previously identified in humans. This review systematically summarizes the risks associ-ated with COPD patients during the COVID-19 pandemic, and systematically elaborates on the characteristics of COPD patients with COVID-19 and the treatment of COPD patients without or with COVID-19, to provide an idea for the protection of COPD population during the epidemic of respira-tory infectious diseases.
文章引用：程晓雨, 冯恩志. 从临床的角度回顾呼吸道传染病对COPD病人影响的研究进展与思考[J]. 临床医学进展, 2023, 13(11): 17307-17314. https://doi.org/10.12677/ACM.2023.13112425

参考文献

[1] Celli, B., Fabbri, L., Criner, G., et al. (2022) Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. American Journal of Respiratory and Critical Care Medicine, 206, 1317-1325. [Google Scholar] [CrossRef] 
[2] Halpin, D.M.G., Celli, B.R., Criner, G.J., et al. (2019) The GOLD Summit on Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Countries. The International Journal of Tuberculosis and Lung Disease, 23, 1131-1141. [Google Scholar] [CrossRef] [PubMed]
[3] 新型冠状病毒感染的肺炎诊疗方案(试行第五版) [J]. 江苏中医药, 2020, 52(2): 96.
[4] 陈蕾, 谢俊刚. 《新型冠状病毒感染诊疗方案(试行第十版)》解读[J]. 医药导报, 2023, 42(3): 308-310.
[5] Myers, L.C., Murray, R., Donato, B., et al. (2023) Risk of Hospitalization in a Sample of COVID-19 Pa-tients with and without Chronic Obstructive Pulmonary Disease. Respiratory Medicine, 206, Article ID: 107064. [Google Scholar] [CrossRef] [PubMed]
[6] Miyashita, K., Hozumi, H., Furuhashi, K., et al. (2023) Changes in the Characteristics and Outcomes of COVID-19 Patients from the Early Pandemic to the Delta Variant Epidemic: A Nationwide Population-Based Study. Emerging Microbes & Infections, 12, Article ID: 2155250. [Google Scholar] [CrossRef] [PubMed]
[7] Pei, L., Chen, Y., Zheng, X., et al. (2023) Comorbidities Prolonged Viral Shedding of Patients Infected with SARS-CoV-2 Omicron Variant in Shanghai: A Multi-Center, Retro-spective, Observational Study. Journal of Infection and Public Health, 16, 182-189. [Google Scholar] [CrossRef] [PubMed]
[8] Somani, S., Richter, F., Fuster, V., et al. (2020) Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19. [Google Scholar] [CrossRef] [PubMed]
[9] Gomez Antunez, M., Muiño Miguez, A., Bendala Estrada, A.D., et al. (2020) Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2. International Journal of Chronic Obstructive Pulmonary Disease, 15. 3433-3445. [Google Scholar] [CrossRef] 
[10] Miwa, M., Nakajima, M. and Goto, H. (2020) Peripheral “Swiss Cheese” Appearance in a COVID-19 Patient with Chronic Obstructive Pulmonary Disease. The American Journal of Tropical Medicine and Hygiene, 103, 546. [Google Scholar] [CrossRef] [PubMed]
[11] Ghosh, S., Nandolia, K.K., Tale, S., et al. (2020) Reverse Batwing Sign in COVID-19 Pneumonia. QJM: An International Journal of Medicine, 113, 836. [Google Scholar] [CrossRef] [PubMed]
[12] Aboumrad, M., Zwain, G., Smith, J., et al. (2023) Development and Validation of a Clinical Risk Score to Predict Hospitalization within 30 Days of Coronavirus Disease 2019 Diagnosis. Military Medicine, 188, e833-e840. [Google Scholar] [CrossRef] [PubMed]
[13] Attaway, A. and Hatipoğlu, U. (2020) Management of Patients with COPD during the COVID-19 Pandemic. Cleveland Clinic Journal of Medicine, 90. [Google Scholar] [CrossRef] [PubMed]
[14] Gupta, S., Batt, J., Bourbeau, J., et al. (2020) Triaging Access to Critical Care Resources in Patients with Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights from the Canadian Thoracic Society (CTS) Position Statement. Chest, 158, 2270-2274. [Google Scholar] [CrossRef] [PubMed]
[15] Hashim, M.J., Alsuwaidi, A.R. and Khan, G. (2020) Population Risk Factors for COVID-19 Mortality in 93 Countries. Journal of Epidemiology and Global Health, 10, 204-208.
[16] Bhutani, M., Hernandez, P., Bourbeau, J., et al. (2020) Key Highlights of the Canadian Thoracic Socie-ty’s Position Statement on the Optimization of COPD Management during the Coronavirus Disease 2019 Pandemic. Chest, 158, 869-872. [Google Scholar] [CrossRef] [PubMed]
[17] Balla, M., Merugu, G.P., Konala, V.M., et al. (2020) Back to Ba-sics: Review on Vitamin D and Respiratory Viral Infections including COVID-19. Journal of Community Hospital In-ternal Medicine Perspectives, 10, 529-536. [Google Scholar] [CrossRef] [PubMed]
[18] Ganji, R. and Reddy, P.H. (2020) Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases. Frontiers in Aging Neuroscience, 12, Article 614650. [Google Scholar] [CrossRef] [PubMed]
[19] Smith, A.A., Fridling, J., Ibrahim, D. and Porter Jr., P.S. (2020) Identifying Patients at Greatest Risk of Mortality Due to COVID-19: A New England Perspective. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 21, 785-789. [Google Scholar] [CrossRef] [PubMed]
[20] Çakir Edis, E. (2020) Chronic Pulmonary Diseases and COVID-19. Thoracic Research and Practice, 21, 345-349. [Google Scholar] [CrossRef] 
[21] Ejaz, H., Alsrhani, A., Zafar, A., et al. (2020) COVID-19 and Comorbidities: Deleterious Impact on Infected Patients. Journal of Infection and Public Health, 13, 1833-1839. [Google Scholar] [CrossRef] [PubMed]
[22] Hess, M.W. (2020) Nebulized Therapy in the COVID-19 Era: The Right Tool for the Right Patient [Letter]. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2101-2102. [Google Scholar] [CrossRef] 
[23] Chen, C.H., Chen, C.Y., Lai, C.C., et al. (2023) The Association between Inhaled Corticosteroid and the Risks of SARS-COV-2 Infection: A Systematic Review and Meta-Analysis. Journal of Infection and Public Health, 16, 823-830. [Google Scholar] [CrossRef] [PubMed]
[24] Akhtar, M.H., Haleem, S., Tauheed, N. and Khan, D. (2023) Dex-medetomidine as Conduit for Non-Invasive Ventilation (NIV) Compliance in COVID-19 and Chronic Obstructive Pul-monary Disease (COPD) Patients in Intensive Care Unit (ICU) Setting: Case Series. Cureus, 15, e33981. [Google Scholar] [CrossRef] [PubMed]
[25] Kwok, W.C., Tsoi, M.F., Leung, S.H.I., et al. (2023) Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting. Viruses, 15, Article 610. [Google Scholar] [CrossRef] [PubMed]
[26] Chudasama, Y.V., Gillies, C.L., Zaccardi, F., et al. (2020) Impact of COVID-19 on Routine Care for Chronic Diseases: A Global Survey of Views from Healthcare Professionals. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 965-967. [Google Scholar] [CrossRef] [PubMed]
[27] Deslée, G., Zysman, M., Burgel, P.R., et al. (2020) Chronic Ob-structive Pulmonary Disease and the COVID-19 Pandemic: Reciprocal Challenges. Respiratory Medicine and Research, 78, Article ID: 100764. [Google Scholar] [CrossRef] [PubMed]
[28] Mora, N., Fina, F., Méndez-Boo, L., et al. (2023) Decline and Uneven Recovery from 7 Common Long-Term Conditions Managed in the Catalan Primary Care after Two Pandemic Years: An Observational Retrospective Population-Based Study Using Primary Care Electronic Health Records. BMC Primary Care, 24, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[29] Leung, J.M., Yang, C.X., Tam, A., et al. (2020) ACE-2 Expres-sion in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19. European Respiratory Journal, 55, Article ID: 2000688. [Google Scholar] [CrossRef] [PubMed]
[30] Chan, K.P.F., Ma, T.F., Kwok, W.C., et al. (2020) Significant Reduction in Hospital Admissions for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Hong Kong during Coronavirus Disease 2019 Pandemic. Respiratory Medicine, 171, Article ID: 106085. [Google Scholar] [CrossRef] [PubMed]
[31] Kim, S.H., Heo, R., Lee, S.K., et al. (2023) The Impact of Wear-ing a Mask on Oxygenation and Hemodynamics in Patients with Mild to Moderate Chronic Obstructive Pulmonary Dis-ease. Annals of the American Thoracic Society, 20, 482-485. [Google Scholar] [CrossRef] 
[32] Liang, Y., Chang, C., Chen, Y., et al. (2020) Symptoms, Management and Healthcare Utilization of COPD Patients during the COVID-19 Epidemic in Beijing. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2487-2494. [Google Scholar] [CrossRef] 
[33] Tan, J.Y., Conceicao, E.P., Wee, L.E., et al. (2021) COVID-19 Pub-lic Health Measures: A Reduction in Hospital Admissions for COPD Exacerbations. Thorax, 76, 512-513. [Google Scholar] [CrossRef] [PubMed]
[34] Kaye, L., Theye, B., Smeenk, I., et al. (2020) Changes in Medication Adherence among Patients with Asthma and COPD during the COVID-19 Pandemic. The Journal of Allergy and Clinical Immunology: In Practice, 8, 2384-2385. [Google Scholar] [CrossRef] [PubMed]
[35] Kwok, W.C., Leung, S.H.I., Tam, T.C.C., et al. (2023) Efficacy of mRNA and Inactivated Whole Virus Vaccines against COVID-19 in Patients with Chronic Respiratory Diseases. Inter-national Journal of Chronic Obstructive Pulmonary Disease, 18, 47-56. [Google Scholar] [CrossRef] 
[36] Huang, L., Liu, Z., Li, H., et al. (2020) The Silver Lining of COVID-19: Estimation of Short-Term Health Impacts Due to Lockdown in the Yangtze River Delta Region, China. GeoHealth, 4, e2020GH000272. [Google Scholar] [CrossRef] 
[37] Wood, M., Walshe, C. and Mccullagh, A. (2023) What Are the Digi-tally Enabled Psychosocial Interventions Delivered by Trained Practitioners Being Offered to Adults with Life-Shortening Illnesses and Palliative Care Needs and Their Informal and Professional Caregivers? A Scoping Review. Palliative & Supportive Care, 21, 727-740. [Google Scholar] [CrossRef] 
[38] Wu, T.T., Jiang, Y.Q., Zhao, B.F., et al. (2023) Real-World COPD Management over 3 Years at the Community Health Service Center of Shanghai during the COVID-19 Pandemic in China. International Journal of Chronic Obstructive Pulmonary Disease, 18, 349-364. [Google Scholar] [CrossRef] 
[39] Latham, S., Sullivan, J., Williams, S., et al. (2020) Maintaining Emo-tional Well-Being during the COVID-19 Pandemic: A Resource for Your Patients. Chronic Obstructive Pulmonary Diseases, 7, 76-78. [Google Scholar] [CrossRef] [PubMed]
[40] Li, Y., Wang, H., Jiang, L., et al. (2023) A Bibliometric Analy-sis of Chronic Obstructive Pulmonary Disease and COVID-19. Medicine, 102, e33240. [Google Scholar] [CrossRef] 
[41] Gruiskens, J., Van Hoef, L., Theunissen, M., et al. (2023) The Psychosocial Impact of the COVID-19 Pandemic on Chronic Care Patients. Journal of the American Medical Di-rectors Association, 24, 426-433.E2. [Google Scholar] [CrossRef] [PubMed]
[42] 张晓伟, 倚丹丹, 王永, 等. 甲流合并肺炎患者预后不良的影响因素[J]. 标记免疫分析与临床, 2022, 29(9): 1492-1496.

为你推荐